A Phase II, Randomized, Placebo-Controlled Study of ATI-7505 [naronapride] in Patients With Chronic Idiopathic Constipation

Trial Profile

A Phase II, Randomized, Placebo-Controlled Study of ATI-7505 [naronapride] in Patients With Chronic Idiopathic Constipation

Discontinued
Phase of Trial: Phase II

Latest Information Update: 06 Nov 2012

At a glance

  • Drugs Naronapride (Primary)
  • Indications Constipation
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 07 Aug 2012 Additional trial locations (Belgium, Germany, United Kingdom) added as reported by European Clinical Trials Database record.
    • 22 Aug 2008 Status changed from in progress to discontinued as reported in an ARYx media release.
    • 22 Aug 2008 Primary endpoint met; results reported in an ARYx Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top